111YI -4.07%56 Receivables Turnover is 16.78 as of Mar. 2026. GuruFocus rates YI with a GF Score™ of 56/100 and a GF Value™ of $6.66 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 116 Medical Distribution companies, 111 ranks better than 99.14% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. 111's Revenue for the
three
months ended in Mar. 2026 was $343 Mil. 111's average Accounts Receivable for the
three
months ended in Mar. 2026 was $20 Mil.
Hence, 111's Receivables Turnover for the
three
months ended in Mar. 2026 was 16.78.
111 (NAS:YI) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
111 Receivables Turnover Related Terms
111 Receivables Turnover Historical Data
* Premium members only.
The historical data trend for 111's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YI vs COSM, HKPD, SNYR: Receivables Turnover Comparison
For the Medical Distribution subindustry, 111's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
111 Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 111's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where 111's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
111 (YI) has a Receivables Turnover of 16.78 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 111 and its competitors. According to the industry distribution chart, 111 ranks #1 out of 116 companies in the Medical Distribution industry, placing it in the top 0.90000000000001%.
Is 111's Receivables Turnover too high?
111's current Receivables Turnover is 16.78. The Medical Distribution industry median Receivables Turnover is 4.55. 111's value of 16.78 is 269.2% above this industry median. Based on the distribution chart, 111 ranks #1 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, 111 has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 111's Receivables Turnover compare to COSM and HKPD?
According to the Medical Distribution industry distribution chart, 111 ranks #1 out of 116 companies for Receivables Turnover. This places 111 in the top 1% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 4.55. 111's value of 16.78 is 269.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 111's current Receivables Turnover of 16.78 is 269.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 111 and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 111's current Receivables Turnover is 16.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 111 stock overvalued right now?
Based on GuruFocus' analysis, 111 (YI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $4.01 — trading 39.8% below its estimated fair value. The current Receivables Turnover is 16.78 and 269.2% above the Medical Distribution industry median of 4.55. 111's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For 111 (YI), the current Receivables Turnover is 16.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 111 (YI) Overvalued in 2026?
Based on GuruFocus' analysis, 111 stock appears to be undervalued.
The current stock price of $4.01 is trading 39.8% below its estimated GF Value™ of $6.66.
GuruFocus considers 111 to be Possible Value Trap.
Key valuation signals for YI:
Receivables Turnover: 16.78
GF Value™: $6.66 vs. price of $4.01 (39.8% below fair value)
Industry Position: 269.2% above the Medical Distribution median (#1 of 116)
No single metric tells the full story. See the YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
56GF Score
Get the complete analysis for YI
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YI has been successfully added to your 
